Skip to Content

How does Besponsa work to treat acute lymphoblastic leukemia (ALL)?

Answers (1)

Official Answer by Drugs.com 10 Oct 2017
Besponsa (inotuzumab ozogamicin), from Pfizer, is a CD22 monoclonal antibody and calicheamicin cytotoxic agent conjugate for relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) in adults. Besponsa works by binding to B-cell ALL cancer cells that express the CD22 antigen and blocks the growth of cancerous cells.
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of cancer is Daurismo (glasdegib) used to treat?

Updated 2 days ago 1 answerFAQ by Drugs.com

What type of drug is Vitrakvi (larotrectinib)?

Updated 2 days ago 1 answerFAQ by Drugs.com

What is the difference between Truxima and Rituxan?

Updated 2 days ago 1 answerFAQ by Drugs.com

What type of leukemia is Xospata (gilteritinib) used to treat?

Updated 2 days ago 1 answerFAQ by Drugs.com

What is the difference between Tolsura and Sporanox?

Updated 24 hours ago 1 answerFAQ by Drugs.com